Search Results (181)

Background: Fluid overload (FO) is a frequent ICU complication and an important predictor of adverse outcomes. While classically attributed to resuscitative fluids, recent data emphasize the contribution of non-therapeutic “fluid creep” from medication diluents and carrier infusions. This study examined associations between fluid creep, FO, acute kidney injury (AKI), and mortality, and explored the predictive value of the modified Renal Angina Index (mRAI) for AKI risk stratification and FO; Methods: A retrospective cohort of 250 critically ill adults (ICU stay ≥72 h) admitted to a mixed medical–surgical ICU between May 2021 and November 2024 was analyzed. All fluids administered during the first 72 h were categorized and indexed to ideal body weight. Fluid creep included drug diluents, carriers, and flushes. FO% was calculated as [(Cumulative Fluid Balance)/IBW] × 100; Results: Fluid creep was higher in non-survivors (5183 ± 2541 vs. 4354 ± 2171 mL; p = 0.008) and correlated with FO, cumulative balance, and total input (r = 0.41 to 0.43; p < 0.001). Creep and FO independently predicted ICU mortality. Abnormal mRAI scores were associated with FO and early AKI; Conclusions: Fluid creep and FO were independent mortality predictors. Routine monitoring and minimization of creep, along with structured de-resuscitation protocols, may improve outcomes in critically ill adults. Full article

Background/Objectives: Patients with chronic kidney disease (CKD) frequently experience upper gastrointestinal (GI) symptoms such as epigastric discomfort, nausea, vomiting, and early satiety. These symptoms can contribute to malabsorption and intermittent dehydration, ultimately accelerating the decline of residual renal function. However, they are often attributed to electrolyte imbalances or fluid overload, and the possibility of underlying gastroparesis is frequently overlooked by both patients and caregivers. This study aimed to provide new insights into the relationship between CKD and gastroparesis through a dual, population-based retrospective analysis that incorporated both inpatient and outpatient data. Methods: From the National Inpatient Sample (NIS) database, 3,579,372 patients diagnosed with gastroparesis, with or without CKD, were identified. From the TriNetX database, 6,263,251 patients presenting to ambulatory clinics with a chief complaint of nausea and vomiting were included. In both datasets, gastroparesis was defined using ICD-10-CM codes. Results: In the inpatient cohort, the prevalence of gastroparesis increased in proportion to CKD severity, with the highest likelihood observed in advanced stages compared to patients without CKD. An increased risk of gastroparesis was also observed in the outpatient CKD cohort from an independent TriNetX database, while the severity-dependent phenotype was not consistent. However, after rigorous propensity score matching, advanced CKD remained significantly associated with higher odds of gastroparesis, with the greatest risk observed in patients with end-stage renal disease (ESRD). Conclusions: These findings, validated across two large and independent datasets representing both inpatient and outpatient populations, demonstrate a consistent association between CKD severity and gastroparesis. They highlight the importance of routine screening and early management of gastroparesis in patients with advanced CKD to improve outcomes and reduce disease burden for CKD patients with sign of early satiety or dyspepsia. Full article

Basic physiology and molecular mechanisms accounting for the maldistribution of fluid that is characteristic of the “third fluid space” (V_t2) have been known for several decades but have been poorly integrated into the clinical literature. Today, the maldistribution can be quantified and simulated in living humans by using volume kinetic mathematics, which introduces possibilities to validate interventions designed to mitigate the pathophysiology. Fluid accumulation in V_t2 occurs both in fluid overload and inflammation, and both are largely influenced by interstitial fluid pressure. This is normally slightly sub-atmospheric but increases during volume loading to eventually exceed the ambient air pressure, whereby the loss of vacuum allows pools of fluid to appear in the interstitial gel. Opening of V_t2 due to fluid overload can be delayed/minimized by lowering the infusion rate, hemorrhage, and the use of hyper-oncotic fluid. Accumulation of fluid in V_t2 during acute inflammation and tissue injury can be explained by disruption of the cell–matrix interactions that actively regulate the interstitial pressure. Inflammatory mediators, mostly tissue cytokines, cause release of tensile forces that disrupt integrin-dependent adhesion between interstitial fibroblasts and collagen fibers. This disruption causes the interstitial space to expand, which results in a deep negative (suction) pressure. These events can be modulated by α-trinositol and insulin. Full article

Diagnosis and treatment of acute exacerbation of interstitial lung disease (AE-ILD) continue to be challenging. The annual incidence of AE in idiopathic pulmonary fibrosis (IPF) is 5% to 15%, with an in-hospital mortality exceeding 50%. Similar annual incidence and mortality rates have been documented in other ILDs. The pathogenic mechanisms underlying AE are not entirely clear, although they could involve an acute injury or inflammatory process in previously affected lung tissue, with histological features of diffuse alveolar damage, similar to acute respiratory distress syndrome. AE-ILD is defined based on the following criteria: acute respiratory worsening within 30 days in a patient with a previous or concurrent diagnosis of ILD accompanied by new bilateral ground-glass abnormalities and/or consolidation on high-resolution computed tomography after ruling out heart failure or fluid overload. Pharmacologic treatments such as corticosteroids, antibiotics, and immunosuppressants have been and continue to be used despite scarce evidence from randomized placebo-controlled clinical trials. Oxygen therapy and ventilatory support are key elements of treatment of AE-ILD. The aim of our article is to provide an updated review on the diagnosis and treatment of AE-ILD and to propose practical algorithms for management. Full article

Objectives: This study evaluated changes in serum sodium (S Na) 24 h after the administration of isotonic versus hypotonic intravenous fluids (IVFs) and the incidences of dysnatremia and hyperchloremic metabolic acidosis. Methods: This double-blind, randomized controlled trial involved children aged 3 months to 5 years who were admitted to a general ward between November 2020 and September 2022 and required IVF. We randomly assigned patients (1:1) to receive either an isotonic solution (D₅0.9%NaCl) or hypotonic solution (D₅0.45%NaCl). Serum electrolyte and venous blood gas levels were obtained at the time of IVF administration and 24 and 48 h after IVF administration. During this study, all participants were monitored for vital signs, body weight, fluid intake and output, and clinical symptoms of dysnatremia. Results: Totals of 69 and 68 patients received isotonic and hypotonic solutions, respectively. The mean age was 1.95 ± 1.25 years in the isotonic group and 1.91 ± 1.32 years in the hypotonic group. The initial degrees of dehydration and biochemical indicators were not different. The change in serum sodium level at 24 h was 2.97 (2.32–3.62) mmol/L in the isotonic group and 2.19 (1.54–2.84) mmol/L in the hypotonic group. In both groups, no significant hyponatremia nor hypernatremia occurred. The incidence of hyperchloremic metabolic acidosis was not different between the groups. Neither group showed any complications. Conclusions: Isotonic fluids may be a preferred option for IVFs in pediatric patients under 5 years of age with medical conditions on a general ward, especially within 24 h, due to their potential to better maintain serum sodium levels without increasing the risk of fluid overload or electrolyte complication. Full article

Sepsis-associated acute kidney injury (SA-AKI) often requires renal replacement therapy (RRT), which markedly alters antimicrobial pharmacokinetics (PK) and pharmacodynamics (PD). Novel β-lactam/β-lactamase inhibitor (BL/BLI) combinations broaden options against multidrug-resistant Gram-negative bacteria, but dosing during RRT remains uncertain. This review summarizes PK/PD features, extracorporeal clearance, and practical dosing considerations about ceftolozane–tazobactam, ceftazidime–avibactam, aztreonam–avibactam, cefiderocol, meropenem–vaborbactam, imipenem–relebactam, and newer agents including sulbactam–durlobactam, cefepime–enmetazobactam, and cefepime–taniborbactam. Pharmacokinetic data, RRT impact, PK/PD targets, pediatric aspects, and clinical outcomes were extracted from experimental models, case reports, and clinical studies. Drug exposure varies with RRT modality, effluent flow, membrane properties, and patient-specific factors such as augmented renal clearance, hypoalbuminemia, and fluid overload. Standard renal-adjusted dosing often yields subtherapeutic concentrations in critically ill patients. Pediatric data remain scarce and largely limited to case reports. Optimal BL/BLI use in septic patients with SA-AKI on RRT requires individualized dosing that accounts for PK/PD variability and dialysis settings. Full-dose initiation during the first 24–48 h, followed by careful adjustment, appears prudent. Therapeutic drug monitoring should be used when available, and institution-specific protocols should be integrated into stewardship programs to improve efficacy and minimize resistance. Full article

Background: Diabetic ketoacidosis (DKA) in patients with kidney failure receiving dialysis presents a formidable clinical challenge. Standard DKA protocols, designed for patients with preserved renal function, often fail in this cohort and can be unsafe when applied without modification. Patients are at risk of iatrogenic fluid overload, dyskalaemia, and hypoglycaemia due to altered insulin kinetics, impaired gluconeogenesis, and the absence of osmotic diuresis. Purpose: This narrative review aims to synthesise current understanding of DKA pathophysiology in dialysis patients, delineate distinct clinical phenotypes, and propose individualised management strategies grounded in physiology-based reasoning, comparative guideline insights, and consensus-supported literature. Methods: We searched PubMed/MEDLINE, Embase, and Google Scholar (January 2004–June 2024) for adult dialysis populations, using terms spanning DKA, kidney failure, insulin kinetics, fluid balance, and cerebral oedema. Reviews, observational cohorts, guidelines, consensus statements, and physiology papers were prioritised; case reports were used selectively for illustration. Evidence was weighted by physiological plausibility and practice relevance. Nephrology-led authors aimed for a pragmatic, safety-first synthesis, seeking and integrating contradictory recommendations. Conclusions: Our findings highlight the critical need for a nuanced approach to fluid management, a tailored insulin strategy that accounts for glucose-insulin decoupling and prolonged insulin half-life, and careful consideration of potassium and acidosis correction. We emphasise the importance of recognising specific volume phenotypes (hypovolaemic, euvolaemic, hypervolaemic) to guide fluid therapy, and advocating the judicious use of variable-rate insulin infusions (‘dry insulin’) to mitigate fluid overload. We also show that service-level factors are critical. Dialysis-specific pathways, interdisciplinary training, and quality improvement metrics can reduce iatrogenic harm. By linking physiology with workflow adaptations, this review provides a physiologically sound, bedside-oriented map for navigating this complex emergency safely and effectively. In doing so, it advances an individualised model of DKA care for dialysis-dependent patients. Full article

Background: Patent ductus arteriosus (PDA) in dogs causes persistent left-to-right shunting, leading to pulmonary overcirculation, left heart volume overload, and potential congestive heart failure. Accurate assessment of fluid imbalance is essential but challenging with conventional echocardiography or biomarkers. Phase angle (PhA), derived from bioelectrical impedance analysis (BIA), may serve as a non-invasive marker of extracellular fluid distribution and cellular integrity. Objectives: This study aimed to evaluate PhA as an indicator of thoracic fluid imbalance in dogs with PDAby analyzing its correlation with pulmonary velocity (PV) and end-diastolic volume (eV), as well as its responsiveness to surgical correction. In addition, we assessed the relationships between PhA and echocardiographic structural indices (LA/Ao, TDI Sep E/Em, TDI Lat E/Em) and examined the influence of the measurement region. Methods: PhA was measured at 5, 50, and 250 kHz in 30 PDA-affected and 15 healthy dogs, with electrode placement across thorax, trunk, and abdomen. Echocardiography evaluated PV, eV, and PDA-specific structural parameters. Results: Thoracic PhA at 5 kHz was significantly reduced in PDAdogs, strongly correlated with PV and moderately with eV. Postoperative measurements showed progressive PhA recovery. Only TDI Lat E/Em correlated with mid-frequency PhA, while other structural indices showed minimal association. Thoracic PhA was lower than trunk or abdominal values, indicating that thoracic measurements may better capture localized extracellular fluid changes in PDAcompared with other regions. Conclusion: Thoracic PhA at 5 kHz effectively reflects extracellular fluid changes in PDA, complements structural echocardiography, and tracks postoperative fluid normalization. Its non-invasive nature supports clinical utility for monitoring hemodynamic burden and therapeutic response. Full article

Osteoarthritis (OA) lacks disease-modifying therapies, in part because key features of the joint microenvironment remain underappreciated. One such feature is localized acidosis, characterized by sustained reductions in extracellular pH within the cartilage, meniscus, and the osteochondral interface despite near-neutral bulk synovial fluid. We synthesize current evidence on the origins, sensing, and consequences of joint acidosis in OA. Metabolic drivers include hypoxia-biased glycolysis in avascular cartilage, cytokine-driven reprogramming in the synovium, and limits in proton/lactate extrusion (e.g., monocarboxylate transporters (MCTs)), with additional contributions from fixed-charge matrix chemistry and osteoclast-mediated acidification at the osteochondral junction. Acidic niches shift proteolysis toward cathepsins, suppress anabolic control, and trigger chondrocyte stress responses (calcium overload, autophagy, senescence, apoptosis). In the nociceptive axis, protons engage ASIC3 and sensitize TRPV1, linking acidity to pain. Joint cells detect pH through two complementary sensor classes: proton-sensing GPCRs (GPR4, GPR65/TDAG8, GPR68/OGR1, GPR132/G2A), which couple to G_s, G_q/11, and G_12/13 pathways converging on MAPK, NF-κB, CREB, and RhoA/ROCK; and proton-gated ion channels (ASIC1a/3, TRPV1), which convert acidity into electrical and Ca²⁺ signals. Therapeutic implications include inhibition of acid-enabled proteases (e.g., cathepsin K), pharmacologic modulation of pH-sensing receptors (with emerging interest in GPR68 and GPR4), ASIC/TRPV1-targeted analgesia, metabolic control of lactate generation, and pH-responsive intra-articular delivery systems. We outline research priorities for pH-aware clinical phenotyping and imaging, cell-type-resolved signaling maps, and targeted interventions in ‘acidotic OA’ endotypes. Framing acidosis as an actionable component of OA pathogenesis provides a coherent basis for mechanism-anchored, locality-specific disease modification. Full article

Background: Acute kidney injury (AKI) frequently complicates the postoperative course in pediatric patients after cardiac surgery and may necessitate renal replacement therapy (RRT). Despite the increasing use of RRT in this population, data on its modalities, outcomes, and prognostic factors remain limited. Methods: This retrospective cohort study included 37 children (aged 2 days–14 years) who underwent RRT in a cardiac intensive care unit (CICU) over a 35-month period. Modalities used were continuous veno-venous hemodiafiltration (CVVHDF) and peritoneal dialysis (PD). Results: The overall mortality was 76%, with no significant difference between RRT modalities. CVVHDF was used in 84% of cases, often during ECMO support. PD was more common in neonates and low-weight infants. Fluid overload and anuria were the leading indications. Survivors were older and heavier. Technical parameters, including blood flow, dialysis dose, and anticoagulation method, were not associated with survival. Conclusions: RRT in pediatric CICU patients is associated with high mortality, independent of modality. Early identification and appropriate patient selection may improve outcomes. Full article

Current passive anti-rollover systems exhibit inadequate adaptability to complex operational environments. Additionally, due to unidentified critical factors driving rollover incidents during landing, the design of active anti-tipping systems for airdrop remains constrained. Given the foregoing circumstances, this paper divides the landing impact process of the vehicle into the airbag cushioning stage and the rigid collision stage. In the airbag cushioning stage, a vertical impact test bench and a fluid–structure interaction (FSI) model is built up to obtain the terminal impact velocity when the airbag’s touching down speed is set as around 8 m/s. An oblique impact test bench and a dynamic model are proposed to investigate the influence of terminal sideslip angles and impact velocities on the vehicle’s roll/pitch stability during the rigid collision phase. Experimental and numerical analyses reveal that the peak overload during the airbag cushioning stage reaches approximately 11 g while the terminal impact velocity in this stage is around 2 m/s. In the rigid collision stage, higher initial descent velocities amplify the peak roll angles and significantly compromise the roll stability. Notably, adjusting the terminal sideslip angle from 90° to 0°/180° triples the critical horizontal velocity threshold from 5.3 m/s to 14.7 m/s which markedly enhances the vehicle’s stability. To address this, an active sideslip angle control system activated at a 250 m altitude is developed to align the vehicle’s horizontal velocity vector with its longitudinal axis to nearly 0°/180° and thus improves the roll/pitch stability. This study establishes a technical foundation for the design of a highly reliable anti-rollover device for the airdrop vehicle. Full article

Background: Right heart failure (RHF) in dogs is marked by pathological fluid redistribution and extracellular fluid (ECF) accumulation, which intensifies cardiac work-load and disrupts systemic homeostasis. This study aimed to validate the clinical utility of phase angle (PhA), a key biomarker derived from bioelectrical impedance analysis (BIA), as a non-invasive and real-time indicator of fluid distribution abnormalities in canine RHF. PhA reflects cellular integrity and fluid balance, making it a promising tool for detecting ECF accumulation, one of the hallmark features of RHF. Additionally, the study assessed the feasibility and clinical applicability of the InBody M20 device in veterinary cardiology, supporting its potential role in monitoring and managing fluid-related complications in dogs with RHF. Methods: A total of 110 canine patients presenting to the Tokyo University of Agriculture and Technology Veterinary Hospital were enrolled and categorized into three groups: right-sided heart failure (RHF), left-sided heart failure (LHF), and healthy controls. Phase angle (PhA) was measured using the InBody M20 device, and plasma osmolality (OSM) was also assessed. Additionally, the effects of body weight and age on PhA values were analyzed to account for potential confounding factors. Results: Dogs in the RHF group exhibited significantly lower phase angle (PhA) values and higher plasma osmolality (OSM) compared to those in the LHF and control groups. A strong positive correlation was observed between PhA and OSM (r = 0.9211, p < 0.0001). Additionally, PhA measured at 5 kHz demonstrated a significant negative correlation with body weight (r = –0.4536, p = 0.0007), while PhA at 50 kHz showed a significant negative correlation with age (r = –0.3219, p = 0.0176). Conclusions: PhA is a reliable and non-invasive biomarker for assessing extracellular fluid accumulation and diagnosing right heart failure in dogs. Its strong correlation with plasma osmolality, as well as its associations with body weight and age, highlights its clinical relevance for comprehensive fluid status evaluation. The findings support the feasibility and applicability of using the InBody M20 device in veterinary cardiology to monitor and manage fluid-related complications in canine patients. Full article

Background: Uraemic cardiomyopathy (UCM), the cardiac manifestation of chronic kidney disease, represents a significant clinical challenge that is often underdiagnosed despite being one of the strongest predictors of mortality in the chronic kidney disease (CKD) population. It develops through pathophysiological mechanisms unique to the uraemic state—left ventricular hypertrophy, myocardial fibrosis, and diastolic dysfunction—that often progress silently, sometimes even without traditional cardiovascular risk factors. Purpose: This review synthesises nephrology-centric mechanisms with clinical phenotypes and contemporary imaging (including CMR T1/T2 mapping and ECV), and proposes a CKD-stage–tailored diagnostic–therapeutic framework. It offers a distinct perspective by integrating the complex pathophysiology of UCM with practical diagnostic approaches and evolving management strategies, differentiating it from prior cardiology-focused overviews. Methods: A comprehensive literature search was conducted across Ovid MEDLINE, Embase, PubMed, Google Scholar, BMJ Best Practice, and UpToDate for studies published up to March 2025. Key findings were extracted from the final evidence set and manually verified for relevance. This review introduces a patho-mechanical cascade model of uraemic cardiomyopathy, integrating toxin-driven, metabolic, and haemodynamic axes. Nephrology-led screening protocols are proposed, leveraging proteomics and strain echo, and advocate mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 (SGLT2) inhibitor initiation at CKD Stage 3a. Cardiorenal clinics are essential for improved outcomes. Key Insights: UCM develops from a multifactorial process. This involves neurohormonal activation, oxidative stress, chronic inflammation, and exposure to toxins such as indoxyl sulfate and p-cresyl sulfate, arising from uraemia. Diagnosis is challenging, masked by overlapping features of fluid overload and anaemia. SGLT2 inhibitors, non-steroidal mineralocorticoid antagonists, and renin–angiotensin–aldosterone system modulation offer promising interventions. The effect of the dialysis modality, its timing, and renal transplantation on cardiac remodelling also emerging from recent studies. Conclusions: UCM sits at the intersection of two failing organ systems. Managing it effectively requires a paradigm shift to incorporate pharmacological and early diagnostic interventions and the integration of cardiology and nephrology care, and the timely implementation of interventions. Full article

Dynamic Line Rating (DLR) is increasingly important for maximizing capacity of existing overhead transmission lines. Conventional thermal rating methods, such as IEEE 738 and model conductors as single, isothermal cylinders and offer limited guidance for multi-conductor bundles, not fully capturing the complex aerodynamic and thermal interactions present in high-voltage networks. This study addresses these limitations by presenting a high-fidelity, two-dimensional coupled thermal-fluid model developed in COMSOL Multiphysics 4.3b. Single and bundled configurations (two-conductor, three-conductor and four-conductor) are analyzed under steady-state conditions using the Shear Stress Transport (SST) turbulence model, accounting for sub-conductor spacing, wind speed, and interactions between temperature distribution and airflow. Simulation results are compared with ampacity calculations from relevant standards to evaluate limitations of simplified models. Results show that leeward conductors reach temperatures up to ~4 °C higher than windward conductors, forming the thermal bottleneck, with peak temperatures of ~103.3 °C versus ~99 °C for single conductors. For bundled conductors, the current required to keep the maximum temperature at 100 °C was calculated, and this value was found to be approximately 3% lower than the current predicted by IEEE 738. The study emphasizes the importance of multiphysics, position-aware simulations to prevent overloading and optimize transmission line utilization. Full article

Control valves are widely applied in nuclear power, offshore oil/gas extraction, and chemical engineering, but suffer from issues like pressure oscillation, flow control accuracy degradation, and motor overload due to unstable fluid loads (e.g., nuclear reactions in power plants and complex marine climates). This paper proposes a dual-motor redundant compensation method to address these challenges. The core lies in a control strategy where a single main motor drives the valve under normal conditions, while a redundant motor intervenes when load torque exceeds a preset threshold—calculated via the valve core’s fluid load model. By introducing excess load torque as positive feedback to the current loop, the method coordinates torque output between the two motors. AMESim and Matlab/Simulink joint simulations compare single-motor non-compensation, single-motor compensation, and dual-motor schemes. Results show that under inlet pressure step changes, the dual-motor compensation scheme shortens the stabilization time of the valve’s controlled variable by 40%, reduces overshoot by 65%, and decreases motor torque fluctuation by 50%. This redundant design enhances fault tolerance, providing a novel approach for reliability enhancement of deep-sea oil/gas control valves. Full article